This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
DCK
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict SKIP-PERMANENT HIGH
Same risk profile as ketamine RC analogs broadly — bladder toxicity at chronic use (ketamine cystitis is the canonical concern), cognitive impairment with frequent use, dissociation-related risk of impulsive behavior. Longer duration than ketamine makes single-session-overshoot harder to recover from. No clinical research program. No biohacking case for Dylan.
▸ Verdict change log
- 2026-06-05 — Initial verdict SKIP-PERMANENT. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.